OBJECTIVE: Morbidly adherent placenta (MAP) affects approximately 1:500 pregnancies. There is a paucity of data evaluating the effect of placental location on diagnosis, risk factors and resultant outcomes in cases of MAP. We analyzed MAP cases to assess if risk factors or maternal outcomes varied based on placental location. STUDY DESIGN: We performed a retrospective chart review of pathology confirmed cases of MAP from patients delivering at two large urban hospitals in the same health system from 2007 -2017. Placental location was defined by ultrasound images and reports. Location was categorized as anterior, posterior, or anterior/posterior for those with placental implantation that involved both sites. Fischer's exact tests and ANOVA for continuous variables were used to examine associations with measures of diagnosis, risk factors, and maternal outcomes. RESULTS: Eighty-six pathology confirmed MAP cases were reviewed. The distribution of placental location on ultrasound was as follows: 19% posterior, 59% anterior, and 22% anterior/posterior. We found that prior cesarean delivery was lower with posterior MAP (63% vs. 94% vs. 84% in the anterior and anterior/posterior groups respectively), p ¼ 0.007; however, IVF rates were significantly higher (38% vs. 2% vs. 5% in the anterior and anterior/posterior groups respectively), p ¼ 0.001. There was also a trend toward a decreased incidence of percreta with posterior MAP than within the anterior and anterior/ posterior groups (19% vs. 47% vs. 58% respectively), p ¼ 0.055.
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Posterior cases were more likely to have diagnosis of MAP made at the time of delivery (50%) compared to anterior (20%) and anterior/posterior (11%) cases p ¼ 0.041. Despite late diagnosis, ureteral injury was the only surgical complication increased in patients with posterior MAP (13% vs. 0% vs. 5% for anterior and anterior/posterior groups respectively), p ¼ 0.037. CONCLUSION: MAP with posterior placental invasion is associated with delayed diagnosis, surgical complications, assisted reproductive technology, and lower numbers of prior cesarean deliveries. These differences in outcomes and risk factors based on placental location may allow for heightened clinical awareness, more case specific patient counseling, and improved management.
848 Can demographic characteristics identify women with self-harm ideation during pregnancy? OBJECTIVE: Because endorsement of thoughts of self-harm can be an antecedent to suicide, identification of self-harm ideation can enable targeted intervention efforts. Our objective was to identify whether maternal characteristics could accurately predict which women report self-harm ideation during pregnancy. STUDY DESIGN: This secondary analysis of a prospective cohort included nulliparous women recruited across 8 centers in the United States. Women were screened twice during pregnancy with an Poster Session IV ajog.org Edinburgh Postpartum Depression Scale (EPDS) (between 6-14 weeks and 22-30 weeks gestation) and categorized according to whether they reported, at either EPDS screen, at least sometime when the "thought of harming myself has occurred". Maternal sociodemographic characteristics and medical history were compared between women who did and did not endorse self-harm ideation in bivariable and multivariable analyses. An ROC curve was generated and AUC estimated to assess the predictive capacity of the model to identify self-harm ideation. RESULTS: Of the 10,038 women included in the original study, 8,817 completed both EPDS screens. Of these women, 470 (5.3%) endorsed self-harm ideation at least once: 306 (3.5%) at the first EPDS screen and 249 (2.8%) at the second screen. Compared with women who did not endorse self-harm ideation, women who did endorse self-harm ideation were younger, and more likely to selfidentify as a racial/ethnic minority, utilize government-funded insurance, have a lower household income, and use tobacco or drugs (Table) . They were less likely to have completed advanced education, a partner/significant other, and intentionally conceived. Including all of these sociodemographic and medical factors into a regression still only yielded fair prediction of self-harm ideation (AUC 0.718). CONCLUSION: Over one in twenty nulliparous pregnant women endorse self-harm ideation at some point during their pregnancy. As sociodemographic and medical characteristics alone did not enable accurate identification, universal assessment for self-harm ideation during pregnancy remains an important aspect of antenatal care.
